EUVIMEDEUVIMED entdecken
Crossref

Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus–Positive Men Who Have Sex With Men (PROBE-C Study)

Malte B Monin iD, Patrick Ingiliz, Thomas Lutz, Stefan Scholten, Christiane Cordes, Maria Martínez-Rebollar, Christoph D Spinner, Mark Nelson, Michael Rausch, Sanjay Bhagani, Lars Peters, Thomas Reiberger und 4 weitere

Clinical Infectious Diseases · 08.02.2023 · 76 (3) · e607-e612

DOI: 10.1093/cid/ciac680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 25.08.2022. Verfasst von Malte B Monin und 15 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: HIV Infections, Hepatitis C, Chronic, Sexual and Gender Minorities, Hepatitis C. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: German Centre for Infection Research (DZIF),, Deutsche Leberstiftung, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Using direct-acting antivirals (DAAs) for recently acquired hepatitis C virus (RAHCV) infections, particularly in human immunodeficiency virus (HIV)–positive men who have sex with men (MSM), dramatically reduced the incidence of hepatitis C. However, implementation into clinical practice is challenging. The aim of this study was to analyze spontaneous clearance (SC) rates of RAHCV and to identify predictors of SC.

Methods

The PROBE-C study is an observational European cohort on RAHCV infections in HIV-positive MSM. Between 2007 and 2017, RAHCV infections were documented with ≥12 months of follow-up. Fisher exact, χ2, and Mann-Whitney U tests were used for statistical analysis.

Results

A total of 464 RAHCV infections were documented; 457 of 464 patients (98%) were male, and the median age (interquartile range [IQR]) was 41 (38–46) years. The main risk group for hepatitis C virus (HCV) transmission was MSM (98.9%). Most participants were infected with HCV genotype 1 (78.3%). The median baseline HCV RNA level (IQR) was 230 000 (135 000–474 432) IU/mL, and the median CD4+ T-cell count was 574/µL (547–604/µL. Of all cases, 92% received combination antiretroviral therapy, with 91% showing suppressed HIV RNA levels (<200 copies/mL). The median maximum alanine aminotransferase level (IQR) was 445 (402–522) U/L. SC of RAHCV infection occurred in 55 of 464 cases (11.9%). A >2-log decline in HCV RNA levels 4 weeks after diagnosis of RAHCV infection was the strongest predictor of SC (P < .001; sensitivity, 96.4%; specificity, 97.5%; positive predictive value, 84.1%; negative predictive value, 99.5%).

Conclusions

SC of RAHCV in HIV-positive MSM is found in only 11.9% of cases and a <2-log drop in HCV RNA level at week 4 after diagnosis should prompt early DAA-based treatment. However, immediate DAA treatment for RAHCV infection may also be favored in patients with ongoing transmission risk behavior.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHepatitis C, ChronicSexual and Gender MinoritiesHepatitis CHIV SeropositivityCoinfectionHumansMaleAdultFemaleHepacivirusHomosexuality, MaleAntiviral AgentsHIVRNA

Stichwörter der Autor:innen

DAA-based treatmentHIV/HCV coinfectionacute HCVrecently acquired hepatitis coinfectionspontaneous clearance

Substanzen

Antiviral AgentsRNA

Autor:innen und Institutionen

  • University Hospital Bonn, Bonn, Germany.
  • German Centre for Infection Research (DZIF), Partner Site Cologne-Bonn, Bonn, Germany.
  • University Hospital Henri-Mondor, Inserm U955-Virus, Hepatology, Cancer, Paris, France.
  • Infektiologikum, Frankfurt/Main, Germany.
  • Praxis Hohenstaufenring, Cologne, Germany.
  • Praxis Cordes, Berlin, Germany.

ORCID-Profile: Malte B Monin

Förderung

  • German Centre for Infection Research (DZIF),
  • Deutsche Leberstiftung
  • European Union

Zitieren

APA

Monin, M. B., Ingiliz, P., Lutz, T., Scholten, S., Cordes, C., Martínez-Rebollar, M., Spinner, C. D., Nelson, M., Rausch, M., Bhagani, S., Peters, L., Reiberger, T., Mauss, S., Rockstroh, J. K., Boesecke, C., & PROBE-C study group (2023). Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus–Positive Men Who Have Sex With Men (PROBE-C Study). Clinical Infectious Diseases, 76(3), e607-e612. https://doi.org/10.1093/cid/ciac680

Vancouver

Monin MB, Ingiliz P, Lutz T, Scholten S, Cordes C, Martínez-Rebollar M, et al. Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus–Positive Men Who Have Sex With Men (PROBE-C Study). Clinical Infectious Diseases. 2023;76(3):e607-e612. doi:10.1093/cid/ciac680

BibTeX
@article{Monin2023,
  author = {Monin, Malte B and Ingiliz, Patrick and Lutz, Thomas and Scholten, Stefan and Cordes, Christiane and Martínez-Rebollar, Maria and Spinner, Christoph D and Nelson, Mark and Rausch, Michael and Bhagani, Sanjay and Peters, Lars and Reiberger, Thomas and Mauss, Stefan and Rockstroh, Jürgen K and Boesecke, Christoph and PROBE-C study group, PROBE-C study group},
  title = {Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus–Positive Men Who Have Sex With Men (PROBE-C Study)},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {3},
  pages = {e607--e612},
  doi = {10.1093/cid/ciac680}
}
Kostenlos starten →